• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.17% Nasdaq Up 1.27%

    Synergy Pharmaceuticals, Inc. (SGYP)

    -NasdaqGS
    4.18 Down 0.18(4.13%) Apr 20, 4:00PM EDT
    |After Hours : 4.18 0.00 (0.00%) Apr 20, 5:23PM EDT
    Add to Portfolio
    Prev Close:4.36
    Open:4.40
    Bid:4.12 x 6000
    Ask:4.17 x 100
    1y Target Est:7.85
    Beta:1.5
    Next Earnings Date:N/A
    Day's Range:4.14 - 4.40
    52wk Range:2.45 - 5.14
    Volume:2,633,652
    Avg Vol (3m):1,566,250
    Market Cap:403.83M
    P/E (ttm):N/A
    EPS (ttm):-1.01
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SGYP

    Comparison

    Symbol% ChgMkt Cap
    SGYPDown 4.13%403.83M
    IRWDUp 1.59%2.16B
    SLXP 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.99
    Quarterly EPS Est (Mar-15) :-0.27
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback